Latest: Achieve accuracy and reliability in cell counting
Latest: Beckman Coulter expands DxI 9000 Immunoassay Analyzer menu
Latest: Bioanalytic breakthroughs redefine drug development
Latest: How to navigate the lab digitalization journey
Latest: SelectScience Analytical Science Summit 2024 – Taking place today!
Latest: Streamline food safety analysis through automation
Latest: Malvern Panalytical launches Revontium at Analytica 2024
SelectScience celebrates medical laboratory professionals
Overcome anti-doping analysis obstacles
Next-generation instrument screens for hemoglobin disorders in newborns
ESCMID modernizes its branding and communications
Analytical measurements supporting cellular therapies
Evolution in gene therapy vector analysis
Managing the risk of nitrosamines in medicinal drugs
Your essential guide to preparative LC
Efficacy of cell reprogramming using 3D spheroid model
New microplate platform with cryopreserved 3D tumor spheroids
Mitigation of liver toxicity with the Akura Twin Microplate
Akura Immune Flow Chip microfluidic 3D spheroid system
How to Buy Cell Counting Equipment
Microplate Readers
How to Buy Microscopy Equipment
How to Buy Water Purification Technology
How to Buy Clinical Laboratory Automation Technology
Biophysical Characterization Technology
ABRF 2024 Annual meeting
21 Apr 24 - 24 Apr 24
Immuno-Oncology Summit...
23 Apr 24 - 25 Apr 24
ESCMID Global 2024
27 Apr 24 - 30 Apr 24
Immunology2024
03 May 24 - 07 May 24
CYTO 2024
04 May 24 - 08 May 24
Advertisement
To support norovirus research and development, The Native Antigen Company offers an extended range of 8 norovirus-like particles, produced from their proprietary VirtuE™ (HEK293) and insect-baculovirus expression systems. Read more...
